{
  "docId": "019de515-46e8-778b-9aa2-edc9d4857990",
  "docSlug": "9b80ae10198fa4f452f4044732defb94",
  "documentTitle": "MaxCyte | Investor Presentation Deck | 17 slides",
  "authorId": "maxcyte",
  "authorName": "MaxCyte",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 10,
  "pageCount": 17,
  "prevPage": 9,
  "nextPage": 11,
  "slideType": "business_model",
  "function": "present_framework",
  "density": "overcrowded",
  "nDataPoints": 8,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de515-46e8-778b-9aa2-edc9d4857990/10",
  "deckHref": "/decks/019de515-46e8-778b-9aa2-edc9d4857990",
  "deckJsonHref": "/decks/019de515-46e8-778b-9aa2-edc9d4857990.json",
  "deckAnchorHref": "/decks/019de515-46e8-778b-9aa2-edc9d4857990#slide-10",
  "components": [
    {
      "bbox": {
        "h": 0.52,
        "w": 0.299,
        "x": 0.638,
        "y": 0.313
      },
      "kind": "diagram",
      "text": "MaxCyte Revenue Model\nAnnual instrument license fee****\nSingle-use disposables\n(processing assemblies)\nStrategic partnership terms\nRazor/razor blade economics and share of\ntherapeutic economics",
      "attrs": {},
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5c2a12ec-d199-4a0b-99d1-25a2ccb42b03",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.448,
        "w": 0.165,
        "x": 0.264,
        "y": 0.313
      },
      "kind": "diagram",
      "text": "MaxCyte Revenue Model\nInstrument sale***\nSingle-use disposables\n(processing assemblies)\nRazor/razor blade economics",
      "attrs": {},
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aedf1672-c061-4ef6-ae87-7a61a4ffe34e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.155,
        "x": 0.805,
        "y": 0.055
      },
      "kind": "image",
      "text": "MaxCyte",
      "attrs": {},
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5ba6dafb-7995-42ba-af45-7f02131fa745",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.29,
        "w": 0.305,
        "x": 0.075,
        "y": 0.45
      },
      "kind": "image",
      "text": "ATX\nST",
      "attrs": {},
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6ef6df4b-6b05-4d8b-9573-34b0b3016908",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.29,
        "w": 0.29,
        "x": 0.49,
        "y": 0.45
      },
      "kind": "image",
      "text": "GTX",
      "attrs": {},
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e3649db8-b6b7-4389-a9c0-7057b9148ad7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.13,
        "w": 0.36,
        "x": 0.071,
        "y": 0.144
      },
      "kind": "list",
      "text": "DRUG DISCOVERY & DEVELOPMENT -\nCells to Discover Drugs\nBlue-chip client base includes the top ten global pharma\ncompanies and 20 of the top 25**",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "789c5c18-f598-4a5d-af49-8c0e3e8bcefd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.13,
        "w": 0.458,
        "x": 0.502,
        "y": 0.144
      },
      "kind": "list",
      "text": "CELL THERAPY - Cells as Drugs\n19 SPL partnerships with cell therapy developers that allow for more\nthan 125 clinical programs*; > $1.55B in potential pre-commercial\nmilestones*",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b435a190-6830-4a38-bff8-a6395337d339",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.015,
        "w": 0.018,
        "x": 0.49,
        "y": 0.962
      },
      "kind": "other",
      "text": "10",
      "attrs": {},
      "subkind": "unclassified",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "49920d5e-428e-4d6c-ac2d-ede2c8107c71",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.36,
        "x": 0.037,
        "y": 0.853
      },
      "kind": "source-note",
      "text": "* Updated as of December 2022\n** Based on 2021 revenue\n*** Includes RUO-non-exclusive license only; $119,000 list price for STx sale\n**** Lease price of $150,000 per year for pre-clinical use or $250,000 per year for clinical use",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a8cd14f1-7b84-435a-b29f-9c10f94d7d04",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.015,
        "w": 0.159,
        "x": 0.82,
        "y": 0.962
      },
      "kind": "source-note",
      "text": "© 2023 MaxCyte, Inc. All Rights Reserved",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f33cd0cb-89f7-445a-935b-22beebdea585",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.539,
        "x": 0.041,
        "y": 0.06
      },
      "kind": "title",
      "text": "Growing Opportunity from R&D to Therapeutics",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "35e00ca2-376b-4b01-8568-5fb8873e9b88",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience Definition",
      "slug": "audience-definition",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "ca334bd6-a0b6-4eed-b95c-fcfcb14e2fe2",
      "evidence": "Growing Opportunity from R&D to Therapeutics",
      "confidence": 0.7
    },
    {
      "name": "Value Proposition Canvas",
      "slug": "value-proposition-canvas",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "f4a2058b-2f36-4257-bcba-e634a3b3165e",
      "evidence": "Razor/razor blade economics and share of therapeutic economics",
      "confidence": 0.6
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 10,
      "from": 10,
      "beatId": "912cac3e-6232-4927-b509-f14666e519bc",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Business Model",
      "beatSlug": "sequoia-pitch-business-model",
      "evidence": "The business model is explained on page 10",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 12,
      "from": 10,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "96682abb-8728-4f5b-8125-f7ceda5bd6f4",
      "evidence": "The deck presents revenue buildup and potential",
      "position": 1,
      "objective": "Showcase revenue potential",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.6,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}